Pfizer expects high single-digit growth over five years starting 2029
On Pfizer's first-quarter earnings call, CEO Albert Bourla was optimistic that in 2029, the company will begin a five-year period of strong growth, with revenue growth rates in the high single digits.
on Pfizer's Q1 earnings call
Where it comes from
Pfizer's CEO believes the growth rate will improve after 2028What the article says
On Pfizer's first-quarter earnings call, CEO Albert Bourla was optimistic that in 2029, the company will begin a five-year period of strong growth, with revenue growth rates in the high single digits.
The Motley Fool